0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Stephen J. Russell
Kura Oncology
20 followers
REVOLUTION Medicines
5 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Century Therapeutics
1 follower
Cabaletta Bio
1 follower
Explore companies